RLAY insider trading — Relay Therapeutics, Inc.
Over the last 90 days, insiders at Relay Therapeutics, Inc. (RLAY) made 0 open-market purchases worth $0 and 4 open-market sales worth $116.48M, making them net sellers by $116.48M. The largest sale was by Svf Pauling (Cayman) Ltd, Softbank Vision Fund (Aiv M2) L.P., Sb Investment Advisers (Uk) Ltd (10% Owner), who sold 6,000,000 shares for $116.40M on Aug 25, 2026.
Updated Oct 16, 2026.
Recent RLAY insider transactions
Every Form 4 filed by Relay Therapeutics, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 7, 2026 | Patel Sanjiv | President and CEO | S · Sale · 10b5-1 | Direct | 48,199 | $18.10 | $872K | Form 4 |
| Oct 6, 2026 | Catinazzo Thomas | Chief Financial Officer | S · Sale · 10b5-1 | Direct | 17,717 | $18.59 | $329K | Form 4 |
| Sep 8, 2026 | Bergstrom Donald A | President, R&D | S · Sale · 10b5-1 | Direct | 8,530 | $18.97 | $162K | Form 4 |
| Sep 8, 2026 | Catinazzo Thomas | Chief Financial Officer | S · Sale · 10b5-1 | Direct | 17,717 | $18.94 | $336K | Form 4 |
| Sep 8, 2026 | Patel Sanjiv | President and CEO | S · Sale · 10b5-1 | Direct | 48,199 | $18.94 | $913K | Form 4 |
| Aug 26, 2026 | Rahmer Peter | See remarks | S · Sale · 10b5-1 | Direct | 4,508 | $20.03 | $90K | Form 4 |
| Aug 25, 2026 | Svf Pauling (Cayman) Ltd, Softbank Vision Fund (Aiv M2) L.P., Sb Investment Advisers (Uk) Ltd | 10% Owner | S · Sale | Indirect | 6,000,000 | $19.40 | $116.40M | Form 4 |
| Aug 17, 2026 | Patel Sanjiv | President and CEO | S · Sale · 10b5-1 | Direct | 48,199 | $20.33 | $980K | Form 4 |
| Aug 14, 2026 | Catinazzo Thomas | Chief Financial Officer | S · Sale · 10b5-1 | Direct | 17,717 | $19.74 | $350K | Form 4 |
| Jul 28, 2026 | Rahmer Peter | See remarks | S · Sale | Direct | 748 | $18.61 | $14K | Form 4 |
| Jul 28, 2026 | Catinazzo Thomas | Chief Financial Officer | S · Sale | Direct | 1,459 | $18.61 | $27K | Form 4 |
| Jul 28, 2026 | Bergstrom Donald A | President, R&D | S · Sale | Direct | 2,237 | $18.61 | $42K | Form 4 |
RLAY insider trading FAQ
Are insiders buying RLAY stock?
Not on the open market. In the last 90 days, Relay Therapeutics, Inc. insiders made no open-market purchases, and 4 open-market sales totaling $116.48M. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading RLAY?
Recent sellers: Bergstrom Donald A, Catinazzo Thomas, Rahmer Peter, Svf Pauling (Cayman) Ltd, Softbank Vision Fund (Aiv M2) L.P., Sb Investment Advisers (Uk) Ltd.
Where does RLAY insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.